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Evaluation of cost savings with the addition of a 
matrix assisted laser desorption ionization-time of flight machine 
(MALDI-TOF) at a tertiary hospital
Hannah Packer PharmD, Ann Wigton PharmD, BCPS
Inpatient Pharmacy Services, St. Cloud Hospital, St. Cloud, Minnesota
Introduction Evaluation
• Matrix assisted laser desorption ionization-time of flight 
mass spectrometry (MALDI-TOF) is a process that can 
identify microbes using either intact cells or cell extracts 
and is rapid, sensitive, and economical.1
• Implementation of a MALDI-TOF has been equal or 
superior to standard methods in the detection and 
identification of organisms.1
• The addition of a MALDI-TOF machine has been 
associated with cost savings at large institutions.2 It is 
unknown if a similar cost advantage can be realized by 
smaller institutions. 
• Currently, at St. Cloud Hospital, certain organisms are 
sent to a secondary facility for identification at an 
increased cost.
• To evaluate potential cost savings of the addition of a 
MALDI-TOF machine in comparison to current costs of 
standard methods at St. Cloud Hospital, a tertiary 
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• When looking at the cost of supplies utilized in testing, it 
would appear that having a MALDI-TOF would provide 
significant cost savings. 
• This cost evaluation does not consider the cost of the 
yearly maintenance contract for the MALDI-TOF, the 
potential decrease in technician time spent during the 
identification process, and whether the savings is large 
enough to offset initial cost of the MALDI-TOF within a 
reasonable time-frame.
• This study does not account for impact on patient length of 
stay or duration of inappropriate antibiotics based on the 
two methods. 
• Based on the cost of supplies to identify an organism, the 
MALDI-TOF has an estimated savings of 94.8% over 
current methods utilized at St. Cloud Hospital.Results
Purpose Conclusion
• A report was generated with the total number of organisms identified at St. Cloud Hospital between July 2016 and June 2017.  A 
microbiology technical specialist identified the cost of supplies utilizing current methods of identification within the microbiology lab and 
obtained a report regarding the total cost of send out identifications during the time period.  A previous study was utilized to identify the 





























*number includes organisms that were sent out for identification that could be identified in house if using MALDI-TOF
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